Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
Thomas W. Geisbert(The University of Texas Medical Branch at Galveston), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Clement Asiedu(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Peter B. Jahrling(National Institutes of Health), Jerome Custers(Johnson & Johnson (Netherlands)), Mario Roederer(National Institutes of Health), Joan B. Geisbert(United States Army Medical Research Institute of Infectious Diseases), Michael Bailey(General Department of Preventive Medicine), Jaap Goudsmit(Harvard University), Maria Grazia-Pau(International AIDS Vaccine Initiative)
Cited by 82
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k